Personal Information
Entreprise/Lieu de travail
Wädenswil, Zürich Switzerland
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.3brain.com
À propos
3Brain is the world's first company to design and produce high-resolution microelectrode arrays (HD-MEAs). Featuring thousands of 3D microelectrodes, these HD-MEA platforms offer unparalleled precision and outperform current market leaders. This cutting-edge technology is the result of 15 years of development and experience with CMOS-MEA chips, which set a new standard for studying electrophysiological activity in brain organoids, slices and tissues, as well as in retinal cultures, in vitro human-derived stem cells and cardiac tissues. Through innovation, 3Brain is committed to advancing research in neuroscience, ophthalmology and cardiology, as well as drug discovery.
Mots-clés
neuron
brain disease
drug discovery
ophthalmology
cardiology
pharmaceutical
biotechnology
electrophysiology
brain
microelectrode array
mea
neuroscience
imaging
biomedical
pharma
stem cells
cmos
drug screening
multielectrode array
partnership
in vitro
dissociated cultures
neuronal network
stem cell
tissue
organoid
Tout plus
Présentations
(1)Personal Information
Entreprise/Lieu de travail
Wädenswil, Zürich Switzerland
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.3brain.com
À propos
3Brain is the world's first company to design and produce high-resolution microelectrode arrays (HD-MEAs). Featuring thousands of 3D microelectrodes, these HD-MEA platforms offer unparalleled precision and outperform current market leaders. This cutting-edge technology is the result of 15 years of development and experience with CMOS-MEA chips, which set a new standard for studying electrophysiological activity in brain organoids, slices and tissues, as well as in retinal cultures, in vitro human-derived stem cells and cardiac tissues. Through innovation, 3Brain is committed to advancing research in neuroscience, ophthalmology and cardiology, as well as drug discovery.
Mots-clés
neuron
brain disease
drug discovery
ophthalmology
cardiology
pharmaceutical
biotechnology
electrophysiology
brain
microelectrode array
mea
neuroscience
imaging
biomedical
pharma
stem cells
cmos
drug screening
multielectrode array
partnership
in vitro
dissociated cultures
neuronal network
stem cell
tissue
organoid
Tout plus